TREATMENT OF A SMALL-CELL LUNG-CANCER CELL-LINE WITH BROMODEOYURIDINECAUSES A DRAMATIC ALTERATION IN PHENOTYPE THAT CORRELATES WITH UP-REGULATION OF THE EXPRESSION OF FIBRONECTIN AND ITS RECEPTOR, ALPHA-5-BETA-1, AND DOWN-REGULATION OF N-MYC EXPRESSION
Tm. Birkenmeier, TREATMENT OF A SMALL-CELL LUNG-CANCER CELL-LINE WITH BROMODEOYURIDINECAUSES A DRAMATIC ALTERATION IN PHENOTYPE THAT CORRELATES WITH UP-REGULATION OF THE EXPRESSION OF FIBRONECTIN AND ITS RECEPTOR, ALPHA-5-BETA-1, AND DOWN-REGULATION OF N-MYC EXPRESSION, The American review of respiratory disease, 147(4), 1993, pp. 716-716